Barclays
MIST icon

Barclays’s Milestone Pharmaceuticals MIST Stock Holding History

Barclays’s Portfolio MIST Stock Details MIST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-100
Closed -$236 – 5436
2024
Q4 		$236 Hold
100
– – ﹤0.01% 5173
2024
Q3 		$152 Hold
100
– – ﹤0.01% 5174
2024
Q2 		$132 Hold
100
– – ﹤0.01% 4746
2024
Q1 		$179 Sell
100
-255,085
-100% -$414K ﹤0.01% 4987
2023
Q4 		$426K Sell
255,185
-390,305
-60% -$1.06M ﹤0.01% 3984
2023
Q3 		$2M Sell
645,490
-155,286
-19% -$483K ﹤0.01% 1900
2023
Q2 		$2.28M Sell
800,776
-46,052
-5% -$174K ﹤0.01% 1807
2023
Q1 		$3.34M Buy
846,828
+205,475
+32% +$751K ﹤0.01% 1816
2022
Q4 		$2.54M Buy
641,353
+100,771
+19% +$530K ﹤0.01% 2093
2022
Q3 		$4.97M Buy
540,582
+328,872
+155% +$2.49M 0.01% 1171
2022
Q2 		$1.3M Sell
211,710
-15,000
-7% -$92.2K ﹤0.01% 2165
2022
Q1 		$1.46M Buy
226,710
+23,697
+12% +$148K ﹤0.01% 2126
2021
Q4 		$1.33M Buy
203,013
+2,325
+1% +$13.9K ﹤0.01% 2640
2021
Q3 		$1.15M Sell
200,688
-3,213
-2% -$18.1K ﹤0.01% 2705
2021
Q2 		$1.12M Buy
203,901
+47,025
+30% +$267K ﹤0.01% 2585
2021
Q1 		$909K Buy
156,876
+119,561
+320% +$875K ﹤0.01% 2834
2020
Q4 		$250K Hold
37,315
– – ﹤0.01% 3640
2020
Q3 		$273K Hold
37,315
– – ﹤0.01% 3649
2020
Q2 		$141K Buy
37,315
+37,266
+76,053% +$120K ﹤0.01% 4312
2020
Q1 		$0 Sell
49
-851
-95% -$14.7K ﹤0.01% 6343
2019
Q4 		$14K Buy
+900
New +$15.9K ﹤0.01% 6048

Other funds holding MIST

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
AFA
Alta Fundamental Advisers New York $265M AUM 98.61% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $69.7B AUM 40.86% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Barclays's MIST Position: Q1 2025 in Review

Barclays sold out of Milestone Pharmaceuticals (MIST) in Q1 2025, closing a stake of 100 shares — an estimated $236 sold.

Barclays first reported a position in MIST in Q4 2019 and held it in 21 quarters. The position peaked at $4.97M in Q3 2022. 43 funds tracked by Wall St. Rank hold MIST as of Q1 2025.

  • Barclays reported no remaining Milestone Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Barclays sold 100 Milestone Pharmaceuticals shares in Q1 2025, an estimated $236.
  • Barclays first reported a position in Milestone Pharmaceuticals in Q4 2019 and held it in 21 quarters.
  • Barclays's Milestone Pharmaceuticals position peaked at $4.97M in Q3 2022.
  • 43 funds tracked by Wall St. Rank held Milestone Pharmaceuticals as of Q1 2025.

Based on Barclays's 13F filing for Q1 2025, filed 15 May 2025.